CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Aakaar Medical Technologies Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Aakaar Medical Technologies Ltd
801, Heritage Plaza
Phone: +91 8452844024p:+91 8452844024 MUMBAI, 400069  India Ticker: AAKAARAAKAAR

Business Summary
Aakaar Medical Technologies Limited is an India-based medical aesthetic company. The Company deals in a range of aesthetic & specialized cosmetic products & devices. Its product range includes both its own brands (domestically manufactured products & internationally manufactured devices) and imported brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It supplies its products and devices primarily to dermatologists, plastic surgeons, and aesthetic physicians, who then sell these products to their end consumers as well as use certain device consumables as part of their treatments. Its products include Lytec Cream, Lytec Gluta, Lytec HYDRA, Lytec Nano C20, Lytec Klense, Lytec SHELL SUNSCREEN, MELINE 02 Dark Circles, MELINE 00 PREP, MELINE 01 Dark Circles, MELINE 01 Ethnic Skin, MELINE 01 ID, MELINE 01 INTIMATE, MELINE 05 PIGMENT HOME MASK, Swyada Snail Mask, Theraderm Aloe soothing complex, TUBELiTE Gold, Regenera Activa AMT, and others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20253/31/2025-----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Bindi D.Meswani 58 7/10/2024 6/20/2013
Chief Executive Officer, Executive Director Rahul B.Sawakhande 44 7/19/2024 6/6/2024
Chief Financial Officer SwetaShah 6/8/2024 1/1/2023
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 14,172,816 (As of 6/27/2025)
Stock Exchange: NSE


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, July 7, 2025